Candidates for minimally invasive mitral valve surgery are people with severe mitral valve disease who meet specific anatomical and vascular requirements that allow surgeons to operate through a small incision in the right side of the chest instead of splitting the breastbone. Not everyone who needs mitral valve surgery qualifies for this approach. About half of patients with severe mitral valve disease aren’t candidates for any surgical intervention due to age or other health conditions, and among those who are, the minimally invasive route requires additional screening.
The Underlying Valve Problem
The first requirement is a mitral valve condition severe enough to warrant surgery. For mitral regurgitation, where the valve leaks blood backward, severity is measured on echocardiography. A leaking jet that covers more than 40% of the left atrium is considered severe, and peak blood flow velocity through the valve typically exceeds 120 cm per second. For mitral stenosis, where the valve is too narrow, severe disease means the valve opening has shrunk to 1.5 square centimeters or less, with very severe cases at 1 square centimeter or below.
The 2020 ACC/AHA guidelines recommend prompt surgical intervention for patients with severe mitral regurgitation who still have preserved heart pumping function. The goal is to fix the valve before the heart muscle starts to weaken and remodel from the extra workload. Some patients with severe regurgitation have no symptoms at all, and exercise testing can help confirm whether that’s truly the case or whether symptoms are being masked by a gradual reduction in activity.
Vascular and Anatomical Requirements
Minimally invasive mitral surgery typically uses the blood vessels in the groin to connect the heart-lung bypass machine, rather than plugging directly into the heart through an open chest. This means your femoral artery needs to be large enough and healthy enough to accommodate the tubing. A femoral artery diameter below 0.6 centimeters is generally considered too narrow. Significant peripheral artery disease, where the blood vessels in the legs and pelvis are clogged or calcified, raises the risk of serious complications like blood vessel tears, backward-traveling blood clots, or aortic dissection during the procedure.
Your ascending aorta also matters. If it’s wider than 4 centimeters, the clamp used to temporarily stop the heart during surgery can’t be safely placed through a small incision. Calcification of the aorta or the mitral valve ring itself can also disqualify you, as it makes the tissue unpredictable during clamping and repair. Chest wall anatomy plays a role too. Conditions like pectus excavatum (a sunken breastbone) or significant scoliosis can make it physically difficult for the surgeon to access the valve through a small right-sided incision.
Conditions That Rule It Out
Several conditions are clear contraindications:
- Previous right chest surgery: Scar tissue and adhesions in the right side of the chest can make it impossible to safely reach the heart. Patients who’ve had radiation therapy to the chest are screened with a CT scan for the same reason, since radiation often causes dense adhesions between the lung and chest wall.
- Moderate to severe aortic regurgitation: A leaky aortic valve interferes with the technique used to protect the heart during surgery.
- Significant aortic root dilation: An enlarged aortic root creates technical and safety problems with cross-clamping.
- Right ventricular dysfunction: A weakened right side of the heart may not tolerate the surgical approach.
- Fixed pulmonary hypertension above 60 mmHg: Persistently high pressure in the lung arteries signals advanced disease that increases operative risk.
- Recent stroke or active cerebrovascular disease: The slightly higher stroke risk with minimally invasive approaches makes this combination too dangerous.
- Severe liver dysfunction or bleeding disorders: Both increase the risk of uncontrollable bleeding.
If severe lung adhesions are discovered during the procedure itself, surgeons sometimes convert to a full sternotomy. This happens in a small percentage of cases but is a known possibility that surgical teams plan for in advance.
How Candidacy Is Evaluated
The screening process involves a dedicated heart team, typically including cardiac surgeons, interventional cardiologists, and echocardiography specialists who review each case together. The standard workup includes several key tests.
A transthoracic echocardiogram (TTE) and 3D transesophageal echocardiogram (TEE) are used to define the exact mechanism of the valve problem, whether it’s a prolapsing leaflet, a torn cord, or another structural issue. This determines whether the valve can be repaired rather than replaced. Echocardiography also screens for aortic valve leakage, which could disqualify the minimally invasive approach.
CT angiography maps the entire vascular system from the chest to the groin. It checks for aortic calcification, aortic dilation, peripheral artery disease, and femoral artery size. The CT also reveals chest wall abnormalities that could complicate surgical access. A coronary angiogram or coronary CT is performed to check for blockages in the heart’s own arteries, since significant coronary artery disease may require a different surgical strategy.
Robotic Surgery Has Additional Restrictions
Robotic-assisted mitral valve repair uses even smaller incisions and robotic arms controlled by the surgeon. It offers excellent precision, but the eligibility criteria are tighter. Even mild aortic valve disease, limited (not severe) peripheral artery disease, or variable pulmonary hypertension above 50 mmHg can be relative contraindications for the robotic platform. Coronary artery disease and moderate lung dysfunction also raise concerns specific to the robotic approach.
The choice between robotic and non-robotic minimally invasive surgery also depends on the surgical team’s experience. Outcomes for both approaches are comparable in skilled hands, but surgeons are advised to have extensive training before switching platforms. In studies comparing the two techniques, patient characteristics were similar, with robotic patients skewing slightly younger and more often male.
Age and Frailty
Advanced age alone doesn’t automatically disqualify someone. Studies of patients 75 and older show that minimally invasive mitral surgery can be performed safely in this group, and patients over 80 have comparable in-hospital outcomes to those aged 75 to 79 when carefully selected. However, patients over 80 tend to have worse kidney function and higher surgical risk scores, reflecting a frailer overall profile. The surgical risk score (EuroSCORE) is the strongest independent predictor of in-hospital mortality, meaning overall health burden matters more than the number on your birthday.
For patients who are truly too frail for any surgery, transcatheter options exist. These catheter-based procedures clip the valve leaflets together through a tube inserted in the groin, avoiding any chest incision entirely. They carry lower short-term risk but may not produce as durable a repair.
Outcomes Compared to Open Surgery
Minimally invasive mitral surgery achieves repair rates above 99% in experienced centers, matching conventional open-heart surgery through a full sternotomy. In a large series of 842 patients, 30-day mortality was just 0.2%. On discharge echocardiography, 90.5% of patients had no meaningful residual leak, and only 0.5% had moderate regurgitation.
One trade-off is a slightly higher stroke risk. A meta-analysis found stroke rates of 2.1% for minimally invasive surgery compared to 1.2% for traditional sternotomy. This is largely attributed to the retrograde blood flow through the femoral artery during bypass, which can dislodge plaque in patients with atherosclerosis. Surgeons can reduce this risk by using the axillary artery (under the collarbone) for bypass in patients with known vascular disease.
Repair rather than replacement also carries kidney benefits, particularly for older patients. A meta-analysis found that valve repair reduced the risk of postoperative kidney failure by about 48% compared to replacement, likely because repair procedures involve shorter time on the bypass machine. Among patients 75 and older, this difference was especially pronounced.
Recovery After Minimally Invasive Surgery
Most patients spend one to two days in the ICU followed by several more days on a regular hospital floor, with total hospital stays averaging about a week. The key advantage over open surgery is the incision. A full sternotomy requires six to eight weeks for the breastbone to heal, during which you can’t lift anything heavy, drive, or do much physical activity. Minimally invasive incisions heal faster because the breastbone is never cut, allowing an earlier return to normal movement and daily activities. Your surgeon will set specific timelines for driving, exercise, and lifting based on how your incision is healing.